Biofeedback therapy used at home is about 70 percent effective at helping patients learn how to coordinate and relax bowel muscles and relieve one of the most difficult-to-treat types of constipation, investigators report.
Researchers from Italy directed by Professor Cammarota have found a unique pattern of microbes living in the esophagus of people with esophageal cancer or Barrett's esophagus, which could potentially be used to identify at-risk individuals and pave the way for new types of treatment in the future.
Data from 20 European national cancer registries was used to analyze trends in incidence rates of young adults with CRC across Europe over the last 25 years.
Microplastics have been found in the human food chain as particles made of polypropylene (PP), polyethylene-terephthalate (PET) and others were detected in human stools, research presented at the 26th UEG Week in Vienna reveals.
In a randomized, placebo-controlled study, researchers from Israel have shown that cannabis can produce clinical remission in up to 65 percent of individuals after eight weeks of treatment, but that this improvement does not appear to result from a dampening down of the underlying inflammatory process.
Children who develop inflammatory bowel disease (ulcerative colitis or Crohn's disease) have an increased risk of death, both in childhood and later in life, a study from Karolinska Institutet in Sweden published in the journal Gastroenterology reports. It is therefore important that patients who are diagnosed as children are carefully monitored, argue the researchers behind the study.
Traditional laxatives are recommended as first-line agents to treat patients with a confirmed diagnosis of opioid-induced constipation, according to a new guideline from the American Gastroenterological Association. If an adequate trial of laxatives results in suboptimal symptom control, the guidelines recommend peripherally-acting mu-opioid receptor antagonist (PAMORA) drugs, namely naldemedine, naloxegol and methylnatrexone.
Crohn's disease has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents a collection of related but slightly different disorders, but until now it has not been possible to predict accurately which subtype of CD a patient is likely to develop.
University of Colorado Cancer Center study shows that CDK1 directly interacts with Sox2 to keep cancer cells 'stemmy.'
A new study from Tufts researchers finds that two inflammatory proteins in the colon increase incrementally with weight. In individuals with obesity, this was accompanied by activation of precancerous cellular pathways.